top of page
Image by Braňo
Latest News
Post: Blog2_Post

Changes to SAHPRA Clinical Trials Application Forms

The updated forms are listed below:

  • The clinical trial application form, CTF 1 form, GLF-CEM-CT-01A_v7_ June 2022 (CTF1), effective from 01 June 2022

  • The clinical trial application form, CTF 1 form, Guidance in conditions of a Public Health Emergency, version 2. 01 June 2022


Please see the changes below, highlighted in RED:

The CTF 1 summary of changes as below

Administrative Changes for implementation, revision to sections Checklist, 2.3, 4.8, 4.9, 4.12, 10.2 and Annexure 1 01 June 2022


Checklist: Must include

  • Certificate of GMP for the manufacture of the Investigational product(s)

  • Evidence of accreditation/Certifications of the designated laboratories

  • Proof of payment (Bank validated)

Section 2.3

Details of investigators and staff (Investigators, staff, number of staff, names, qualifications, experience preferably in a table and include the titles of investigators involved)


Section 4.8

Estimated Quantity of Trial Material (each medicine detailed separately) for which exemption will be required (including overage and justification for overage if above 20 %) include supplemental medical devices e.g testing kits and concomitant medicines to be imported.


Section 4.9

If any of the above medicines/medical devices are available in South Africa, give an explanation of why they need to be imported from elsewhere.

Section 4.12

Details of the manufacture, quality control and stability of the IP. Provide a certificate of GMP for the manufacture of the IP.


Section 10.2

Provide Statistical method(s) and analysis of qualitative and/or quantitative measures with appropriate, clear justification. Provide the statistical analysis plan if available

Changes to the annexure 1 of the CTF 1

Progress report changes

  • GLF-CEM-CT-06A_v4_Six Monthly Progress Report Form_ June 2022

  • Addition of sections 13, 14 and 15

  • Document number changed from 6.27 to GLF-CEM-CT-06A

Section 13

Provide proof of current registration on the South African National Clinical Trials Registry (SANCTR)

13.1 DoH Number

13.2 Enclose transcript reflecting current information from SANCTR


Section 14

Provide the summary of the investigational product:

  • Authorized for importation

  • Imported

  • Used during the Clinical Trial

  • Destroyed (include the destruction certificate(s)) and

  • Quantity to be exported or exported

14.1 Overall comment on Investigational Product Reconciliation


Section 15

The planned date for provision of trial results to SAHPRA and SANCTR (applicable to the final progress report)

Members are reminded to always refer to the SAHPRA website when competing for a new application: https://www.sahpra.org.za/clinical-trials-application-and-report-forms/

Comentarios


bottom of page